PVLA

AS OF

Dec 24 closing price

Price

$105.83

Change

+$5.56 (+5.55%)

Capitalization

1.25B

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

PVLA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Palvella Therapeutics (PVLA) Ownership - Who owns Palvella Therapeutics?

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

PVLA

Capitalization

1.25B

P/E Ratio

14.22

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

63.6M

Total Cash/Share

5.37

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

38.7M

P/B Ratio

32.36

Cash Flow

N/A

Earnings

-2.92

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

11K

Current Ratio

6.49

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-27.57M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-48.36

Shares Held By Institutions

633M

Shares Outstanding - Current

11.8M

Total Liabilities

28.3M

Total Volume MTD

N/A

Value

-1

Gain YTD

781.917

View a ticker or compare two or three

Compare

PVLA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for PVLA

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details